Peer Review History
| Original SubmissionDecember 19, 2022 |
|---|
|
PONE-D-22-34361Octopamine and tyramine signalling in Aedes aegypti: molecular characterization and insight into potential physiological roles.PLOS ONE Dear Dr. Finetti, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, methodological questions were raised regarding the statistical analyses and greater clarity was requested regarding the expression profile interpretation of the biosynthetic enzymes. Please submit your revised manuscript by Mar 10 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, J Joe Hull, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: "The authors would like to thank Dr. Federica Albanese (Toronto Western Research Institute) for language revision and Dr. Jimena Leyria (University of Toronto Mississauga) for ongoing advice during the project. This research was supported by NSERC Discovery Grants to JPP, IO and ABL. " We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This research was supported by NSERC Discovery Grants to JPP, IO and ABL. " Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript gives a good contribution in the identification and molecular characterization of four OA and three TA receptors in A. aegypti and their putative physiological roles based on transcript expression profile analysis will be useful for better understanding complex mechanisms such as reproduction and osmoregulation in this important vector of several human diseases. However, I have concerns about the methods, results and discusssion of the ms that I believe need to be addressed in order to improve its clarity. Their approach is interesting but it has some flaws that make this version unacceptable for publication. My main concern: 1- Line 122: Why did you choose 12/12 instead of 8/16 D/L cycle? 2- Line 301: I would suggest to put subheading as a sentence instead of question form. 3- Line 303: What do authors mean with (Female A. aegypti require a blood meal for egg production and it is also true that this process imposes some stress on the insect?) 4- Line 316: Unfed means starved or sugar-fed? First, because it is well known that starvation stimulate stess hormone, octopamine, the counterpart of adrenaline in vertebrates and consequently alter the expression level of the corresponding receptors. Second, did authors compare their control at the same time points? 5- Heat maps included in figure (4-7) did not add more information especially no significant difference among chosen time points are found. 6- Line 422: The expression level of Tβh in males is highly upregulated, however, tests (the only exclusive organ to males among all chosen organs) show very low expression level, from where this difference appear? How? 7- Lines 484-486: According to Fig.8, this upregulation was not statistically significant, you should not magnify your results if they are not statistically significant. I suggest to focus on the most important and statistically significant data in the whole ms. 8- Line 501: Did you compare statistically the expression level of tdc with the expression level of Tβh? If not, how did you conclude that tdc was more highly expressed than Tβh in MTs? 9- Line 517-518: Regarding the sentence (and has not been highly investigated in reproductive organs but was shown to be present in D. melanogaster female reproductive organs (El-Kholy et al., 2015). I suggest to delete this sentence because El-Kholy et al (2015) detect very weak TyRII expression level in male and female reproductive system (almost nothing) but the strongest expression of this receptor was detected in intestine and MTs. 10- Lines (526-530): Regarding the sentence (Surprisingly, blood feeding did not affect the expression profile of TA and OA receptors in the brain of female mosquitoes. On the other hand, transcripts encoding the enzymes responsible for the synthesis of TA and OA, respectively Tdc and Tβh, showed dynamic profiles, with peaks in the first hours after blood feeding, suggesting that blood intake induces a strong synthesis of both TA and OA), This means that in female mosquitoes, blood meal induce more OA and TA to be synthetized but without any consequent change in their related receptors, please explain. 11- Line 505: Revise the written mistakes in all references in the text for example replace (El-Kholi et al. 2015) with (El-Kholy et al. 2015). Reviewer #2: The authors have included most of my recommendations. However, there are a few concerns that have not been addressed: Introduction: Line 68: I would not consider Wolbachia a genetic technique. Perhaps, authors meant “genetic techniques or Wolbachia infected mosquitoes”? Results: Line 214: Introduce abbreviation “Oaα2” In the figures, it is still not clear to me which significance levels a-b mean, and which group they are compared to, does the statistics refer to comparisons to the reference genes?. Please, explain. Did they use Bonferroni, Dunnet or Tukey methods? The explanation is not consistent in the Methods and figure captures. Results: “…associated with smell and taste” and hearing? I do not think the references has been included: Georgiades M, Alampounti CA, Somers J, Su M, Ellis D, Bagi J, et al. A novel beta-adrenergic like octopamine receptor modulates the audition of malaria mosquitoes and serves as insecticide target [Internet]. bioRxiv; 2022 [cited 2022 Sep 13]. p. 2022.08.02.502538. This reference can also be discussed in 491-495. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Samar El-Kholy Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Octopamine and tyramine signalling in Aedes aegypti: molecular characterization and insight into potential physiological roles. PONE-D-22-34361R1 Dear Dr. Finetti, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, J Joe Hull, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-34361R1 Octopamine and tyramine signalling in Aedes aegypti: molecular characterization and insight into potential physiological roles. Dear Dr. Finetti: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. J Joe Hull Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .